BOXR-889

N/A

Report date: 2025/01/26 17:19:50

Base Information

Drug NameBOXR-889
Drug Alias Nameanti-FOLRA CAR T-cell therapy 2 (Unum Therapeutics)anti-folate receptor alpha CAR T-cell therapy 2 (Unum Therapeutics)BOXR-889
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionFolate receptor alpha modulators
TargetsFolate receptor alpha
Therapy Area/IndicationsOvarian NeoplasmsCarcinoma, Endometrioid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCogent Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCogent Biosciences Inc
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsCarcinoma, Endometrioid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A